Elizabeth Holmes & Theranos | 60 Minutes Archive

60 Minutes archive piece on Elizabeth Holmes and Theranos, exposing how the blood-testing startup's Edison device failed and its claims to investors were fabricated.

Key Takeaways

Theranos's technology never worked as advertised, and its public and investor claims were deliberately misleading.
Prestige, celebrity status, and powerful board members helped a fraudulent healthcare company avoid early scrutiny.
Internal whistleblowers and fear of retaliation play a critical role in exposing corporate fraud.
Fabricated medical data posed real risks to patients, not just financial harm to investors.

What the video covers

Elizabeth Holmes founded Theranos at 19 after dropping out of Stanford, promising a device that could run hundreds of lab tests from a finger prick.
At its peak Theranos was valued near $10 billion, making Holmes the youngest self-made female billionaire.
Insiders including Tyler Schultz and Erica Chung say the Edison device malfunctioned and could not complete tests accurately.
Employees say investor demonstrations were staged, with tests actually performed by hand in the lab while visitors were shown a bait-and-switch.
Theranos raised nearly $900 million from investors based on claims of FDA validation, pharma partnerships, and military use that were fabricated.
Former scientist Doug Matthew says test data submitted to the FDA was falsified and bad results were made to disappear under pressure.
Patient results were sent to Walgreens customers despite contradictory retests, and patients were not informed of the uncertainty.
Day-to-day operations were run by president Ramesh 'Sunny' Balwani, Holmes's secret boyfriend, who enforced a culture of intimidation.
Holmes and a board packed with prominent figures lent the company credibility, while employees were bound by non-disclosure agreements and legal pressure.
The SEC charged Holmes and Balwani with massive fraud; Holmes settled without admitting guilt and paid a fine.

Chapters

What was Theranos's main claim about its technology?

Theranos claimed its Edison device could run hundreds of laboratory blood tests from a small finger prick, at a fraction of the cost of traditional labs. Insiders say the device could not perform tests accurately.

How did Theranos mislead investors according to the video?

Employees say investor demonstrations were staged, with the real testing done by hand in the lab. The company also made false claims about FDA validation, pharma partnerships, and military deployment in investor documents.

What happened to Elizabeth Holmes and Sunny Balwani legally?

The SEC charged both with massive fraud. Holmes settled the case without admitting guilt and paid a half-million dollar fine, while Balwani faced the remaining charges.

Full Transcript — Download SRT & Markdown

Speaker A

Elizabeth Holmes was just 19 years old when she dropped out of Stanford University with a dream of creating a company that would revolutionize blood testing. She founded the startup Theronos and boasted her technology could take a pin prick worth of blood

Speaker A

from the finger and perform hundreds of laboratory tests. It was, she claimed, quote, the most important thing humanity has ever built. At its zenith, Theronos was worth nearly $10 billion. And Elizabeth Holmes became the youngest self-made female billionaire in the

Speaker A

world. She was also, as the Wall Street Journal uncovered, at the center of a massive multi-year fraud. You're about to hear from insiders how the Theronos deception hoodwinkedked gullible investors and worse, endangered unsuspecting patients.

Speaker A

Our work is in being able to make testing more accessible. Elizabeth Holmes built her company Theronos on this invention she named the Edison, a miniaturized blood analyzer that would disrupt the $60 billion lab testing industry dominated by giants LabCorp and

Speaker A

Quest Diagnostics. Holmes called her invention the iPod of healthcare and it made her a celebrity. She graced magazine covers and was praised by politicians and the press alike.

Speaker A

You founded this company 12 years ago, right? Tell them how old you were. I was 19.

Speaker A

She sold her vision with grandiose claims that her blood tests would cost a fraction of current prices. Hol's biotech startup was backed by an illustrious board packed with national security heavyweights like Henry Kissinger and James Mattis, the current

Speaker A

defense secretary. The board was filled with friends of George P. Schultz, the former Secretary of State who helped end the Cold War. He introduced his grandson Tyler to Holmes. Dazzled, Tyler Schultz became a believer and joined the company

Speaker A

soon after getting his degree in biology from Stanford University. When you met her and you heard about Elizabeth Holm's vision, what did you think?

Speaker A

I was totally sold on it. Tyler Schultz began working at Therronos in September 2013. It was a pivotal moment as the company announced a partnership with Walgreens. The deal would put an Edison machine in every store. Elizabeth Holmes claimed the

Speaker A

Edison performed all the tests big lab machines like these could. From cholesterol to cancer, all from a painless finger prick. But Tyler Schultz says the Edison he saw just didn't work.

Speaker A

Was it a sophisticated piece of machinery? No. There were components that would kind of fall off in the middle of testing that you would have to then fish out. They had doors that wouldn't close.

Speaker A

They would get too hot and then they would get too cold. When I was there, we could not complete any test accurately on the devices that we were manufacturing.

Speaker A

Doug Matche joined Theronos in 2012 after getting his doctorate in biochemistry. His job was to adapt blood tests for the Edison tests which Holmes told investors were ready to use on patients. But Elizabeth Holmes had told Walgreens in 2010 that it had developed

Speaker A

this device that was capable of running any blood test from a few drops pricricked from a finger in real time and less than half the cost of traditional labs. Was that true?

Speaker A

No, certainly not. Do you think she was lying to Walgreens? I do. Yeah. Are you a clinical lab specialist? No.

Speaker A

Erica Chung was fresh out of Berkeley with a degree in molecular and cell biology when she went to work at Theronos. She was just 22, but even the novice lab tech suspected something was very wrong when she saw faulty test

Speaker A

results sent to Walgreens patients. And when did you think I probably shouldn't be doing this?

Speaker A

Uh pretty pretty soon in the process, especially when we started to pick up more patient samples. And when those samples were retested, she says there were often contradictory results.

Speaker A

Did you ever alert the patient? No, we didn't let them know, hey, we reran your patient's sample and we're not actually positive about what the diagnosis is.

Speaker A

This is someone's health information. Exactly. This isn't uh an app crashing. This isn't, you know, someone's food delivery coming late. It's just a different ballgame.

Speaker A

It's not the only game Elizabeth Holmes was playing. Theronos employees told us they were instructed to stage fake demonstrations for investors who visited company headquarters.

Speaker A

It was kind of a show. All they would see was their blood getting collected.

Speaker A

They didn't see what was going on behind closed doors about how it was processed.

Speaker A

They would get their finger pricricked with a small amount of blood. Then they'd be led out of the room. They'd go have a meeting, go have lunch, whatever.

Speaker A

And at which point an engineer would run in the room, grab the cartridge, bring it out into the lab.

Speaker A

So, was the Edison doing the testing? No, absolutely not. Who was doing the testing?

Speaker A

It was scientists at the bench by [snorts] hand. By hand. Yeah. It was a bait and switch for investors that kept the money rolling in. Theronos raised nearly $900 million from those investors who now say they were swindled

Speaker A

by Elizabeth Holmes and company president Romesh Sunonny Balwani. The pair claimed in investor documents obtained by 60 Minutes that Theronos technology was validated by the FDA pharmaceutical companies and was deployed on the battlefield by the US military in Afghanistan. Those claims

Speaker A

were fabricated and in one public appearance after another, Holmes's pitch became even more fantastic and reckless.

Speaker A

We've done some work with people at Hopkins who have developed and demonstrated that in blood you can see the onset of pancreatic cancer 17 years before a tumor forms. We called John's Hopkins Medicine. They told us they never

Speaker A

collaborated with Theronos and Doug Matchy says test data he compiled for the Food and Drug Administration was falsified.

Speaker A

There was so much pressure from above to get good-looking results that are going to be able to pass um FDA guidelines that people were pressured into making things disappear.

Speaker A

The bad results. The bad results. That's deceptive. Yeah, for sure. Did you ever go to your boss and say, "This isn't right." Absolutely. All the time. But, you know, he was under a lot of pressure from the people above him and he was trying to do

Speaker A

his best to make to make everyone happy. This invention is going to be way up there um with with with the discovery of antibiotics. Uh day-to-day operations were run by company president Sunonny Balwani. It's an incredible Balwani is a millionaire software

Speaker A

engineer with no training in the biological sciences, but he did have a powerful connection to Elizabeth Holmes.

Speaker A

Sunonny Balwani was her secret boyfriend. Some people are here because of the mission, the cause. Some people are hopefully here for the science.

Speaker A

Balwani was also Holmes enforcer, firing employees on the spot and berating scientists for failed tests. After a year and a half, Matche quit. I saw that there was, you know, potentially fraud taking place. There was far too much

Speaker A

illegitimate things going on there. I talked to Sunny, decided I didn't want to be there anymore, and I left.

Speaker A

Tyler Schultz was also becoming disillusioned. I had a personal relationship with Elizabeth. She was close to my family and I felt like she was deceiving my family and the public.

Speaker A

And almost every media outlet, including us here at CBS, bought into the Theronos myth.

Speaker A

A healthcare pioneer is being compared to visionaries like Bill Gates and Steve Jobs. Do you think she wanted to be the next Steve Jobs?

Speaker A

She just really idolized him, so she wore the black turtleneck. I think she created a world where she was Steve Jobs for a little bit.

Speaker A

As her wealth and reputation soared, Elizabeth Holmes took on the trappings of power. She bragged bulletproof windows were installed in her office and she traveled with a full-time security detail. Theronos employees told us they were closely watched and required to

Speaker A

sign non-disclosure agreements. All reinforced, they said, by a threatening team of lawyers and private investigators.

Speaker A

That's why when Tyler Schulz alerted authorities in the spring of 2014, he used a fake name. Why did you come up with an alias?

Speaker A

I knew how seriously Theronos protected their trade secrets. I knew they would not take it well if they knew that I was talking to regulators.

Speaker A

In his email to New York State Department of Health regulators, Schultz outlined questionable lab practices and said he believed test results were being switched. I just said, "This happened in my laboratory and I just want to know if

Speaker A

this is okay." And they responded and said, "No, this is cheating. This is not how it's supposed to be done." Tyler Schultz was ready to resign, but first he sent Elizabeth Holmes an email about his concerns. He got a response

Speaker A

from Sunny Balwani. that I was arrogant, ignorant, patronizing, reckless, and I was lacking the basic understanding of math, science, and statistics. That if I had any other last name that I would have already been held accountable to the strongest extent.

Speaker A

Tyler Schulz quit in April 2014, and soon after, Erica Chung did too. By February 2015, the Theronos fairy tale was about to unravel publicly. At the Wall Street Journal, Puliter Prizewinning reporter John Keroo, who has written a book about the Theronos

Speaker A

saga got a call. It was a tipster casting doubt about the Edison, Theronos, and its charismatic founder, Elizabeth Holmes.

Speaker A

She is a pathological liar. She wanted to be a celebrated tech entrepreneur. uh she wanted to be rich and famous and she wouldn't let anything get in the way of that.

Speaker A

What kind of job did the board do in holding Holmes accountable? This is one of the most epic failures in corporate governance in the annals of American capitalism. They did nothing to verify that her scientific claims were true. Keroo's first article appeared in

Speaker A

October 2015 and revealed Theronos did less than 10% of its tests on Edison machines.

Speaker A

What do you think's going on here? Holmes struck back. This is what happens when you work to change things and first they think you're crazy, then they fight you, and then all of a sudden you change the world. Breath of

Speaker A

But skeptics were no longer buying the Theronos deception. What I'm showing you now is the result of hundreds of engineers and scientists work.

Speaker A

Holmes repeatedly insisted she would present proof at a major industry conference that her technology worked.

Speaker A

You can see the tray dropping into the detection module. There it was proof that never came and the evidence that you presented fell far short of that. In 2016, after a series of surprise inspections, federal regulators shut down the company's

Speaker A

laboratory, saying it posed immediate jeopardy to patient health and safety. Nearly 1 million Theronos test results were invalidated.

Speaker A

When she started using this technology on blood samples taken from consumers in Walgreens stores, that was an unauthorized medical experiment. There's no other way to put it.

Speaker A

Theronos was on the brink of collapse. Bigname investors found their stock was worthless. Education secretary Betsy Devos and her family and media mogul Rupert Murdoch each lost more than $100 million.

Speaker A

Walgreens sued Theronos and settled for less than a quarter of their 140 million investment. Why do you think this was outright fraud as opposed to any other Silicon Valley startup that just wasn't able to deliver on lofty goals?

Speaker A

Well, because she raised money, hundreds of millions of dollars uh on the basis of this technology not only being ready and working, but being commercially rolled out. You're also lying to the public. You're lying to patients. You're lying to doctors. You're lying to

Speaker A

regulators. Most people would call that fraud as well. The Securities and Exchange Commission called it massive fraud when they charged Elizabeth Holmes and Sunonny Balwani in March. Holmes settled the SEC case without admitting guilt and paid a half a million dollar fine. Balwani, who

Speaker A

left Theronos two years ago, calls the SEC charges unwarranted and is fighting them. At its height, how much was Therronos worth?

Speaker A

$10 billion. There was a period of several months where it was more valuable than Uber, more valuable than Airbnb, more valuable than Spotify.

Speaker A

And how much is it worth now? Zero.

Topics:TheranosElizabeth HolmesSunny Balwanihealthcare fraudblood testingEdison deviceinvestigative journalismwhistleblowerSilicon Valley60 Minutes

Get More with the SozAI App

Transcribe recordings, audio files, and YouTube videos — with AI summaries and speaker detection. 30 minutes free.

App Store Google Play

Or transcribe another YouTube video here →

Free tools: TXT to SRT · SRT Validator · Merge SRT · Subtitle to Text · All tools